These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15285438)

  • 1. Auto-antibody testing in obstetric patients.
    Tikly M; McHugh N
    S Afr Med J; 2004 Jul; 94(7):498. PubMed ID: 15285438
    [No Abstract]   [Full Text] [Related]  

  • 2. Antinuclear antibody testing in obstetric patients.
    Afman IE; Cronjé HS; Joubert G; Badenhorst PN; Schoon MG
    S Afr Med J; 2003 Dec; 93(12):932-7. PubMed ID: 14750494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doppler ultrasound in obstetric practice: 2.
    Beattie RB
    Br J Hosp Med; 1994 Jan 19-Feb 1; 51(1-2):34-9. PubMed ID: 8826041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinuclear antibodies in women with recurrent pregnancy wastage and their prognostic value for immunotherapy.
    Malinowski A; Szpakowski M; Wilczyński J; Oszukowski P; Puchała B; Włodarczyk B
    Zentralbl Gynakol; 1994; 116(11):631-5. PubMed ID: 7871915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical utility of a positive antinuclear antibody test result.
    Abeles AM; Abeles M
    Am J Med; 2013 Apr; 126(4):342-8. PubMed ID: 23395534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of antinuclear antibodies in women with recurrent pregnancy losses: a prospective controlled study.
    Harger JH; Rabin BS; Marchese SG
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):419-24. PubMed ID: 2783770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the high-risk lupus pregnant patient.
    Witter FR
    Rheum Dis Clin North Am; 2007 May; 33(2):253-65, v-vi. PubMed ID: 17499706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibodies predicts a poor IVF-ET outcome: impaired egg and embryo development and reduced pregnancy rate.
    Ying Y; Zhong YP; Zhou CQ; Xu YW; Wang Q; Li J; Shen XT; Wu HT
    Immunol Invest; 2012; 41(5):458-68. PubMed ID: 22429204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary study of antiphospholipid antibodies in 50 cases of bad obstetric history.
    Kaneria MV; Vishwanathan C
    J Assoc Physicians India; 1999 Jul; 47(7):669-72. PubMed ID: 10778583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinuclear autoantibodies in women with recurrent pregnancy loss.
    Ticconi C; Rotondi F; Veglia M; Pietropolli A; Bernardini S; Ria F; Caruso A; Di Simone N
    Am J Reprod Immunol; 2010 Dec; 64(6):384-92. PubMed ID: 20482520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic significance of antinuclear antibodies].
    Glass AS; Bossuyt PM
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1087. PubMed ID: 10850116
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic factors and reproductive success in women with primary repeated spontaneous abortion.
    Gloria-Bottini F; Nicotra M; Magrini A; Bottini E
    Fertil Steril; 2010 Feb; 93(3):1014-5. PubMed ID: 19800064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of antinuclear antibody testing in unexplained second and third trimester fetal deaths.
    Incerpi MH; Banks EH; Goodwein SN; Samadi R; Goodwin TM
    J Matern Fetal Med; 1998; 7(2):61-4. PubMed ID: 9584815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
    Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
    Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study of the ELISA and IF methods for antinuclear antibody test].
    Shiba N; Note R; Hayashi S; Ozawa T; Niiya K; Sakuragawa N
    Rinsho Byori; 1997 Feb; 45(2):175-8. PubMed ID: 9121002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational diabetes: an evaluation of serum fructosamine as a screening test in a high-risk population.
    Agarwal MM; Dhatt GS; Othman Y; Ljubisavljevic MR
    Gynecol Obstet Invest; 2011; 71(3):207-12. PubMed ID: 21160150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinuclear antibody, is it a risk factor for cerebral ischemia? Magnetic resonance image analysis, a preliminary study.
    Kurokawa Y; Ishizaki E
    Comput Med Imaging Graph; 2008 Sep; 32(6):423-8. PubMed ID: 18524538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
    Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
    Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus.
    Jearn LH; Kim DA; Kim TY
    J Rheumatol; 2009 Aug; 36(8):1833-4. PubMed ID: 19671822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.